Shinsuke Mizutani

661 total citations
50 papers, 400 citations indexed

About

Shinsuke Mizutani is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Shinsuke Mizutani has authored 50 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 21 papers in Pathology and Forensic Medicine and 18 papers in Oncology. Recurrent topics in Shinsuke Mizutani's work include Lymphoma Diagnosis and Treatment (18 papers), Viral-associated cancers and disorders (10 papers) and Multiple Myeloma Research and Treatments (9 papers). Shinsuke Mizutani is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Viral-associated cancers and disorders (10 papers) and Multiple Myeloma Research and Treatments (9 papers). Shinsuke Mizutani collaborates with scholars based in Japan, United States and Australia. Shinsuke Mizutani's co-authors include Junya Kuroda, Yuji Shimura, Masafumi Taniwaki, Tsutomu Kobayashi, Shigeo Horiike, Yoshiaki Chinen, Yosuke Matsumoto, Miki Kiyota, Hisao Nagoshi and Mio Yamamoto‐Sugitani and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Shinsuke Mizutani

45 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinsuke Mizutani Japan 11 188 127 121 115 58 50 400
Danielle Shafer United States 12 169 0.9× 85 0.7× 118 1.0× 151 1.3× 48 0.8× 30 398
Miki Kiyota Japan 10 137 0.7× 107 0.8× 104 0.9× 93 0.8× 101 1.7× 23 319
Jonathan A. Schumacher United States 11 137 0.7× 122 1.0× 89 0.7× 62 0.5× 65 1.1× 25 374
Matko Kalac United States 9 220 1.2× 161 1.3× 47 0.4× 148 1.3× 89 1.5× 37 423
Harald Biersack Germany 13 219 1.2× 116 0.9× 196 1.6× 242 2.1× 71 1.2× 33 560
Plamen Kossev United States 9 185 1.0× 165 1.3× 122 1.0× 238 2.1× 101 1.7× 13 611
Neil Palmisiano United States 13 156 0.8× 128 1.0× 162 1.3× 228 2.0× 120 2.1× 64 491
Cristina Bugarin Italy 13 153 0.8× 66 0.5× 273 2.3× 142 1.2× 197 3.4× 26 605
Normann Steiner Austria 14 219 1.2× 108 0.9× 180 1.5× 191 1.7× 54 0.9× 55 471
Sangeeta Nischal United States 5 254 1.4× 80 0.6× 216 1.8× 128 1.1× 62 1.1× 9 463

Countries citing papers authored by Shinsuke Mizutani

Since Specialization
Citations

This map shows the geographic impact of Shinsuke Mizutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinsuke Mizutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinsuke Mizutani more than expected).

Fields of papers citing papers by Shinsuke Mizutani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinsuke Mizutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinsuke Mizutani. The network helps show where Shinsuke Mizutani may publish in the future.

Co-authorship network of co-authors of Shinsuke Mizutani

This figure shows the co-authorship network connecting the top 25 collaborators of Shinsuke Mizutani. A scholar is included among the top collaborators of Shinsuke Mizutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinsuke Mizutani. Shinsuke Mizutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimura, Yuji, Akio Onishi, Takahiro Fujino, et al.. (2025). Late-Onset Angioimmunoblastic T-cell Lymphoma During Nivolumab Treatment for Melanoma. Cureus. 17(7). e89042–e89042.
2.
Fujino, Takahiro, Taku Tsukamoto, Shinsuke Mizutani, et al.. (2024). Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma. Hematological Oncology. 42(1). e3252–e3252. 6 indexed citations
3.
Mizutani, Shinsuke, Taku Tsukamoto, Takahiro Fujino, et al.. (2024). Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities. Leukemia. 39(1). 211–221. 1 indexed citations
4.
Onishi, Akio, Yuji Shimura, Takahiro Fujino, et al.. (2023). Progressive Multifocal Leukoencephalopathy Initially Suspected As Brain Relapse From Classical Hodgkin’s Lymphoma. Cureus. 15(8). e44000–e44000.
5.
Onishi, Akio, Shinsuke Mizutani, Taku Tsukamoto, et al.. (2023). Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms. Infection and Drug Resistance. Volume 16. 509–519. 3 indexed citations
6.
Tsukamoto, Taku, Masakazu Nakano, Hiroaki Nagata, et al.. (2023). miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma. Cancer Science. 115(2). 452–464. 3 indexed citations
7.
Mizutani, Shinsuke, Alexandra L. Garnham, Connie S.N. Li Wai Suen, et al.. (2023). Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis. Cell Death and Differentiation. 30(6). 1447–1456. 2 indexed citations
8.
Onishi, Akio, Yuji Shimura, Takahisa Nakamura, et al.. (2023). Management of Acquired Factor X Deficiency Caused by <i>In Vitro</i> Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid Therapy. Internal Medicine. 62(16). 2401–2406.
9.
10.
Kobayashi, Tsutomu, Mitsushige Nakao, Ryoichi Takahashi, et al.. (2022). Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study. Cancer Medicine. 12(3). 3134–3144. 4 indexed citations
11.
Uoshima, Nobuhiko, Takahiro Fujino, Taku Tsukamoto, et al.. (2021). Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma. Diagnostics. 11(9). 1724–1724. 5 indexed citations
12.
Kamitsuji, Yuri, Nana Sasaki, Yasuhiko Tsutsumi, et al.. (2021). Durable Remission of Chemotherapy-Refractory Myeloid Sarcoma by Azacitidine. The Tohoku Journal of Experimental Medicine. 254(2). 101–105. 4 indexed citations
13.
Hayakawa, Naoki, Shinsuke Mizutani, Tomohiro Agou, et al.. (2018). Synthesis and Characterization of N-Heterocyclic Carbene-Coordinated Silicon Compounds Bearing a Fused-Ring Bulky Eind Group. Inorganics. 6(1). 30–30. 11 indexed citations
14.
Tsukamoto, Taku, Masakazu Nakano, Ryuichi Sato, et al.. (2017). High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif. Scientific Reports. 7(1). 14039–14039. 14 indexed citations
15.
Mizutani, Shinsuke, Junya Kuroda, Nana Sasaki, et al.. (2016). Quadruple Cancers of Non-producing Multiple Myeloma, Cholangiocellular Carcinoma, and Two Different Thyroid Cancers. Internal Medicine. 55(9). 1183–1186. 1 indexed citations
16.
Tsukamoto, Taku, Miki Kiyota, Eri Kawata, et al.. (2016). Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era. International Journal of Hematology. 105(5). 658–667. 5 indexed citations
17.
Chinen, Yoshiaki, Junya Kuroda, Yuji Shimura, et al.. (2014). Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma. Cancer Research. 74(24). 7418–7429. 28 indexed citations
18.
Kuroda, Junya, Mio Yamamoto‐Sugitani, Sayori Wada, et al.. (2013). Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells. Leukemia Research. 38(1). 103–108. 14 indexed citations
19.
Shimura, Yuji, Junya Kuroda, Masaki Ri, et al.. (2012). RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma. Molecular Cancer Therapeutics. 11(12). 2600–2609. 28 indexed citations
20.
Kiyota, Miki, Tsutomu Kobayashi, Shin‐ichi Fuchida, et al.. (2012). Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma. International Journal of Hematology. 95(5). 516–526. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Shafer Breakdown of academic impact, for papers by Miki Kiyota Breakdown of academic impact, for papers by Jonathan A. Schumacher Breakdown of academic impact, for papers by Matko Kalac Breakdown of academic impact, for papers by Harald Biersack Breakdown of academic impact, for papers by Plamen Kossev Breakdown of academic impact, for papers by Neil Palmisiano Breakdown of academic impact, for papers by Cristina Bugarin Breakdown of academic impact, for papers by Normann Steiner Breakdown of academic impact, for papers by Sangeeta Nischal
Rankless by CCL
2026